31.54 million from 2017. The selling expenses such as shipping fees also dropped in the same line with the decreased in sales in the period. However, during the year, the Company has financial advisory

as the Company has more effective policy to collect debts. Furthermore, the selling expenses such as shipping fees dropped in the same line with the decreased in sales in the period. The loss on

IP: INTER PHARMA PUBLIC COMPANY LIMITED L&E: LIGHTING & EQUIPMENT PUBLIC COMPANY LIMITED PAP: PACIFIC PIPE PUBLIC COMPANY LIMITED PRINC: PRINCIPAL CAPITAL PUBLIC COMPANY LIMITED PSL: PRECIOUS SHIPPING

building and Baht 10.0 Million from loss on change in fair value less cost to sale of biological assets, resulted from changing of fair price of fattening pigs in 2019 less than 2018. Financial Cost

. Gross profit margin decreased from the increased of cost of services while the price was remain and from changing the law regarding to the provision of long-term employee benefits from the 300 days to 400

book value per share at 16.58 times and debt to equity ratio (D/E ratio) at 0.36 times. Cash Flow For the 9-month period as of June 30, 2017, the Company had the changing in cash flow comparing to the

55.69% in the first quarter of 2021 due to some reduction of orders from clients and the Company’s process of changing its customer base while also preparing to accommodate new clients this year. Moreover

enhance the capability to develop new products to catch up with the technology changing and the dynamic marketing. Operating profit in Q1-19 totaling Baht 979 million or Baht 71 million down from the same

income lower than target. o Changing the fiscal accounting year of the company in Malaysia to be ending at December caused the customers to buy a big volume in last December 2018 and reflect to less buying

force investments for new product development and enhancement to catch up with the rapidly changing technology and the dynamics of borderless marketing. Operating profit in Q2-19 totaled Baht 658 million